Lucigen Corp.

Lucigen Corporation was acquired by LGB Biosearch Technologies. Lucigen worked to improve people’s lives by providing quality biomedical products and services used across the spectrum from basic research to molecular diagnostics. We manufacture and sell over 325 biomedical research products to life-science and healthcare professionals worldwide. Lucigen leverages its expertise in enzyme evolution and core competencies that support a variety of applications such as synthetic biology, next gen sequencing, and human diagnostics. Lucigen’s acquisition of Epicentre products expanded our portfolio offering into array-based analysis, in vitro transcription, nucleic-acid extraction purification, and transposon mutagenesis. As an ISO 13485-certified company, we proudly offer catalog and custom solutions to meet researchers’ expanding needs, including OEM partnerships.